TrialThe Journal of clinical endocrinology and metabolism2012

Impact of mifepristone, a glucocorticoid/progesterone antagonist, on HDL cholesterol, HDL particle concentration, and HDL function.

Stephanie T Page et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.